This market study covers the growth prospects of the cardiac rhythm management devices market in China with segmentations based on product type (pacemakers, ICDs, and CRT devices). It also includes an insightful analysis of the leading vendors in this market, including BIOTRONIK, Boston Scientific, LivaNova, and Medtronic.
Technavio’s market research analysts estimate the cardiac rhythm management market in China, which is expected to grow at a CAGR of 10% by 2020. Rising incidences of cardiac disorders such as atrioventricular blocks, ventricular fibrillation, cardiac arrest, bradycardia, sick sinus syndrome, and tachycardia is expected to increase the demand for cardiac rhythm management devices in China during the forecast period. The market will witness increasing sales of biventricular cardiac resynchronization therapy (CRT)-Ds and CRT-Ps during eth forecast period, owing to their declining, average selling process (ASPs).
The new market research report from Technavio provides a breakdown and analysis of the cardiac rhythm management segments by technology.
“One of the latest trends gaining prominence in this market is the increasing popularity of robot-assisted cardiac surgery. The robot-assisted devices help surgeons perform sophisticated procedures by providing a better visualization platform and maneuvering of instruments compared to traditional devices. Also, these minimally invasive surgical procedures help reduce the duration of hospital stays and facilitate better cost management. Also, these procedures also prevent human errors and ensure improved outcomes, reduced recovery periods, and minimal pain and discomfort,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research
In this market research, the analyst predicts the pacemakers segment will dominate the market with a market share of close to 64% until the end of 2020. Pacemakers use low-energy electric pulses to induce the patient’s heart to beat at a normal rate. The new-generation pacemakers can adjust heart beat rate based on the patient’s activity.
Segmentation of cardiac rhythm management devices market in China by product 2020
Source: Technavio, 2016
The leading vendors in the cardiac rhythm management market in China are BIOTRONIK, Boston Scientific, LivaNova, and Medtronic. This market presents significant opportunities for the vendors to expand. Both large and small companies are investing substantially in R&D to develop innovative products. The demand for cost-effective cardiac rhythm management devices has also led the local manufacturers to develop new-age products.
A more detailed analysis is available in the Technavio report, Cardiac Rhythm Management Market in China 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
